Roswell Park Comprehensive Cancer Center in Buffalo has named Eunice Wang, MD, Medical Director of Infusion Services for Roswell Park’s Chemotherapy and Infusion Centers. Dr. Wang will oversee infusion services on the main campus and at Roswell Park’s satellite clinics, focused on a patient-centric approach to care and treatment plans. She will continue in her role as Chief of Leukemia. Dr. Wang has served in multiple roles since joining Roswell Park in 2003, including Co-Chair of the Leukemia Translational Research Group and Physician Leader with the Chemotherapy and Infusion Center.
Eunice Wang, MD
Candace S. Johnson, PhD
“Dr. Wang is a fierce and attentive patient advocate, which makes her the ideal person to lead Infusion Services,” says Candace S. Johnson, PhD, President & CEO and M&T Bank Presidential Chair in Leadership at Roswell Park. “Her passion for outstanding care will be a guiding force for this important clinical program.”
Dr. Wang earned her medical degree from the Keck School of Medicine, University of Southern California, and completed residency training in internal medicine at Yale-New Haven Hospital, Yale University. She completed a clinical hematology-oncology and research fellowship at Memorial Sloan Kettering Cancer Center. Her research focuses on the development of early-stage clinical trials for acute leukemias and myeloproliferative disorders.
Recently, Dr. Wang has proved pivotal in disseminating information about patient care and safety at Roswell Park during the COVID-19 pandemic, having appeared on social media and television specials.
